Varying correlation between 18F-fluorodeoxyglucose positron emission tomography and dynamic contrast-enhanced MRI in carotid atherosclerosis: Implications for plaque inflammation

Stroke

Volumn 45, Issue 6, 2014, Pages 1842-1845

  Wang, Juan ^a   Liu, Hongbin ^a   Sun, Jie ^b   Xue, Hao ^a   Xie, Leixing ^a   Yu, Shengyuan ^a   Liang, Changzai ^a   Han, Xu ^a   Guan, Zhiwei ^a   Wei, Liqun ^a   Yuan, Chun ^b,c   Zhao, Xihai ^c   Chen, Huijun ^c  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Tsinghua University   (China)

Author keywords

atherosclerosis; carotid arteries; magnetic resonance imaging; positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROGENESIS; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CYTOKINE PRODUCTION; FEMALE; HUMAN; MACROPHAGE; MALE; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SOFT TISSUE INFLAMMATION; ULTRASOUND; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY DISEASE; CLINICAL TRIAL; INFLAMMATION; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY;

ATHEROSCLEROSIS; CAROTID ARTERIES; MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY;

AGED; CAROTID ARTERY DISEASES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INFLAMMATION; MACROPHAGES; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 84901919962     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.005147     Document Type: Article

References (12)

1. Stoll G, Bendszus M. Infammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke. 2006;37:1923-1932.
2. Libby P. Infammation in atherosclerosis. Nature. 2002;420:868-874.
3. Tawakol A, Migrino RQ, Bashian GG, Bedri S, Vermylen D, Cury RC, et al. In vivo 18F-fuorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque infammation in patients. J Am Coll Cardiol. 2006;48:1818-1824.
4. Graebe M, Pedersen SF, Højgaard L, Kjaer A, Sillesen H. 18FDG PET and ultrasound echolucency in carotid artery plaques. JACC Cardiovasc Imaging. 2010;3:289-295.
5. Kerwin WS, O'Brien KD, Ferguson MS, Polissar N, Hatsukami TS, Yuan C. Infammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. Radiology. 2006;241:459-468.
6. Gaens ME, Backes WH, Rozel S, Lipperts M, Sanders SN, Jaspers K, et al. Dynamic contrast-enhanced MR imaging of carotid atherosclerotic plaque: model selection, reproducibility, and validation. Radiology. 2013;266:271-279.
7. Folco EJ, Sheikine Y, Rocha VZ, Christen T, Shvartz E, Sukhova GK, et al. Hypoxia but not infammation augments glucose uptake in human macrophages: implications for imaging atherosclerosis with 18fuorine-labeled 2-deoxy-D-glucose positron emission tomography. J Am Coll Cardiol. 2011;58:603-614.
8. Rudd JH, Myers KS, Bansilal S, Machac J, Pinto CA, Tong C, et al. Atherosclerosis infammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantifcation methods, and recommendations. J Nucl Med. 2008;49:871-878.
9. Fisher RA. Statistical Methods for Research Workers. 14th ed. Edinburgh, UK: Oliver and Boyd; 1970.
10. Leitinger N, Schulman IG. Phenotypic polarization of macrophages in atherosclerosis. Arterioscler Thromb Vasc Biol. 2013;33:1120-1126.
11. Spagnoli LG, Mauriello A, Sangiorgi G, Fratoni S, Bonanno E, Schwartz RS, et al. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA. 2004;292:1845-1852.
12. Redgrave JN, Lovett JK, Gallagher PJ, Rothwell PM. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. Circulation. 2006;113:2320-2328.